Literature DB >> 17550938

Early Trends in PaO(2)/fraction of inspired oxygen ratio predict outcome in lung transplant recipients with severe primary graft dysfunction.

Matthew E Prekker1, Cynthia S Herrington, Marshall I Hertz, David M Radosevich, Peter S Dahlberg.   

Abstract

BACKGROUND: The development of severe primary graft dysfunction (PGD) is a risk factor for perioperative death following lung transplantation. Our goal is to improve the predictive value of the earliest Pao(2)/fraction of inspired oxygen (P/F) measurements that gauge PGD severity.
METHODS: We identified 96 patients with severe PGD (P/F < 200) at ICU arrival through a retrospective review of 431 lung transplants performed at our institution from 1992 to 2005. The P/F trend, represented as quartiles of the 12-h percentage change in P/F, was analyzed using multivariate logistic regression. Study outcomes were 90-day death and long-term survival.
RESULTS: The median percentage change in P/F over 12 h was + 52% (interquartile range, +20 to 90%). We observed the highest early mortality among those in the lowest quartile of the P/F trend (an increase in P/F <or= 20%). Ninety-day death rates decreased across the quartiles (low quartile, 32%; low-mid quartile, 9%; high-mid quartile, 5%; high quartile, 5%; test for trend, p = 0.007). After adjustment for the use of cardiopulmonary bypass, those in the lowest quartile of P/F trend had 6.8 times the odds of early death vs patients with a more favorable trend (odds ratio, 6.80; 95% confidence interval, 1.73 to 0.51; p = 0.007). In the first 5 years after transplant, there were significantly more deaths within the low quartile group vs those with a more rapidly increasing P/F trend (log-rank test, p = 0.01).
CONCLUSIONS: Among lung recipients with severe PGD at ICU arrival, an improvement in P/F <or= 20% in the first 12 h portends a poor outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17550938     DOI: 10.1378/chest.06-2752

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  CASE 7--2014 Rescue therapy with early extracorporeal membrane oxygenation for primary graft dysfunction after bilateral lung transplantation.

Authors:  Ali M Farooki; Heidi Bazick-Cuschieri; Emily K Gordon; James C Lee; Edward C Cantu; John G Augoustides
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-08-30       Impact factor: 2.628

2.  Postoperative estradiol levels associate with development of primary graft dysfunction in lung transplantation patients.

Authors:  Julie A Bastarache; Joshua M Diamond; Steven M Kawut; David J Lederer; Lorraine B Ware; Jason D Christie
Journal:  Gend Med       Date:  2012-02-22

3.  Construct validity of the definition of primary graft dysfunction after lung transplantation.

Authors:  Jason D Christie; Scarlett Bellamy; Lorraine B Ware; David Lederer; Denis Hadjiliadis; James Lee; Nancy Robinson; A Russell Localio; Keith Wille; Vibha Lama; Scott Palmer; Jonathan Orens; Ann Weinacker; Maria Crespo; Ejigaehu Demissie; Stephen E Kimmel; Steven M Kawut
Journal:  J Heart Lung Transplant       Date:  2010-07-22       Impact factor: 10.247

Review 4.  Primary graft dysfunction.

Authors:  Yoshikazu Suzuki; Edward Cantu; Jason D Christie
Journal:  Semin Respir Crit Care Med       Date:  2013-07-02       Impact factor: 3.119

5.  Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.

Authors:  Edward Cantu; Joshua M Diamond; Yoshikazu Suzuki; Jared Lasky; Christian Schaufler; Brian Lim; Rupal Shah; Mary Porteous; David J Lederer; Steven M Kawut; Scott M Palmer; Laurie D Snyder; Matthew G Hartwig; Vibha N Lama; Sangeeta Bhorade; Christian Bermudez; Maria Crespo; John McDyer; Keith Wille; Jonathan Orens; Pali D Shah; Ann Weinacker; David Weill; David Wilkes; David Roe; Chadi Hage; Lorraine B Ware; Scarlett L Bellamy; Jason D Christie
Journal:  Am J Respir Crit Care Med       Date:  2018-01-15       Impact factor: 30.528

Review 6.  Proposed management algorithm for severe hypoxemia after liver transplantation in the hepatopulmonary syndrome.

Authors:  D Nayyar; H S J Man; J Granton; L B Lilly; S Gupta
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.